Toxicity and efficacy of sirolimus: Relationship to whole-blood concentrations
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22, B93-B100
- https://doi.org/10.1016/s0149-2918(00)89026-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- PIVOTAL PHASE III MULTICENTER, RANDOMIZED, BLINDED TRIAL OF SIROLIMUS VERSUS AZATHIOPRINE IN COMBINATION WITH CYCLOSPORINE AND PREDNISONE IN PRIMARY RENAL TRANSPLANTSTransplantation, 1999
- Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejectionThe Journal of Thoracic and Cardiovascular Surgery, 1999
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1Transplantation, 1998
- EFFECTS OF THE PHARMACOKINETIC INTERACTION BETWEEN ORALLY ADMINISTERED SIROLIMUS AND CYCLOSPORINE ON THE SYNERGISTIC PROLONGATION OF HEART ALLOGRAFT SURVIVAL IN RATS1Transplantation, 1996
- SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL1Transplantation, 1996
- Rapamycin: Distribution, Pharmacokinetics, and Therapeutic Range InvestigationsTherapeutic Drug Monitoring, 1995
- Renal effects of rapamycin in the spontaneously hypertensive ratTransplant International, 1994
- PROLONGATION OF CANINE PANCREATIC ISLET ALLOGRAFT SURVIVAL WITH COMBINED RAPAMYCIN AND CYCLOSPORINE THERAPY AT LOW DOSESTransplantation, 1993
- THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1Transplantation, 1993